Sponsors: []Modifications: or Part 9, Charitable Prescription DrugRecycling Actmeans the same as that term isdefinedA:(a)  accept and redistribute an unused drug under Part 9, Charitable Prescription DrugRecycling Act; or(b)(i)(ii)(iii)(iv)(v)(vi)redistributing     58-17b-901.This part is known as the "Charitable Prescription Drug Recycling Act."     58-17b-902.As used in this part:(1)  "Assisted living facility" means the same as that term is defined in Section 26-21-2.(2)  "Cancer drug" means a drug that controls or kills neoplastic cells and includes adrug used in chemotherapy to destroy cancer cells.(3)  "Charitable clinic" means a charitable nonprofit corporation that:(a)  holds a valid exemption from federal income taxation issued under Section 501(a),Internal Revenue Code;(b)  is exempt from federal income taxation under Section 501(c)(3), Internal RevenueCode;(c)  provides, on an outpatient basis, for a period of less than 24 consecutive hours, toan individual not residing or confined at a facility owned or operated by the charitablenonprofit corporation:(i)  advice;(ii)  counseling;(iii)  diagnosis;(iv)  treatment;(v)  surgery; or(vi)  care or services relating to the preservation or maintenance of health; and(d)  has a licensed outpatient pharmacy.(4)  "Charitable pharmacy" means an eligible pharmacy that is operated by a charitableclinic.(5)  "County health department" means the same as that term is defined in Section26A-1-102.(6)  "Donated prescription drug" means a prescription drug that an eligible donordonates to an eligible pharmacy under the program.(7)  "Eligible donor" means a donor that donates a prescription drug from within thestate and is:(a)  a nursing care facility;(b)  an assisted living facility;(c)  a licensed intermediate care facility for people with an intellectual disability;(d)  a manufacturer;(e)  a pharmaceutical wholesale distributor;(f)  an eligible pharmacy; or(g)  a physician's office.(8)  "Eligible pharmacy" means a pharmacy that:(a)  is registered by the division as eligible to participate in the program; and(b)  is operated by:(i)  a county;(ii)  a county health department;(iii)  a pharmacy under contract with a county health department;(iv)  the Department of Health, created in Section 26-1-4;(v)  the Division of Substance Abuse and Mental Health, created in Section62A-15-103; or(vi)  a charitable clinic.(9)  "Eligible prescription drug" means a prescription drug, described in Section58-17b-904, that is not a controlled substance.(10)  "Licensed intermediate care facility for people with an intellectual disability"means the same as that term is defined in Section 58-17b-503.(11)  "Medically indigent individual" means an individual who:(a)  is eligible to receive Medicaid or Medicare; or(b)  does not have health insurance and lacks reasonable means to purchase prescribedmedications.(12)  "Nursing care facility" means the same as that term is defined in Section26-18-501.(13)  "Physician's office" means a fixed medical facility that:(a)  is staffed by a physician, physician's assistant, nurse practitioner, or registerednurse, licensed under Title 58, Occupations and Professions; and(b)  treats an individual who presents at, or is transported to, the facility.(14)  "Program" means the Charitable Prescription Drug Recycling Program created inSection 58-17b-903.(15)  "Unit pack" means the same as that term is defined in Section 58-17b-503.(16)  "Unlawful conduct" means the same as that term is defined in Sections 58-1-501and 58-17b-501.(17)  "Unprofessional conduct" means the same as that term is defined in Sections58-1-501 and 58-17b-502.     58-17b-903.(1)  There is created the Charitable Prescription Drug Recycling Program.(2)  The division, in consultation with the board, shall:(a)  implement the program, on a statewide basis, to permit an eligible donor to transferan eligible prescription drug to an eligible pharmacy for dispensing to a medically indigentindividual;(b)  in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act,make rules necessary to implement the program; and(c)  provide technical assistance to entities that desire to participate in the program.     58-17b-904.An eligible pharmacy may not accept or dispense an unused prescription drug under theprogram unless the unused prescription drug:(1) (a)  is in the original sealed unit pack; or(b)  is an injectable medication;(2) (a)  is unopened; or(b)  is a cancer drug packaged in an unopened single-unit dose that has been removedfrom a multi-dose package;(3)  is accepted and dispensed by the eligible pharmacy before:(a)  a beyond use date that appears on the label;(b)  the expiration date recommended by the manufacturer; or(c)  a date, established by division rule for a specific prescription drug, in accordancewith Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date inSubsection (3)(a) or (3)(b);(4) (a)  is not adulterated or mislabeled; and(b)  the pharmacist or licensed pharmacist technician accepting or dispensing theprescription drug does not have reason to believe that the prescription drug is adulterated ormislabeled.     58-17b-905.(1)  An eligible donor or an eligible pharmacy may participate in the program.(2)  An eligible pharmacy:(a)  shall comply with all applicable federal and state laws related to the storage anddistribution of a prescription drug;(b)  shall comply with all applicable federal and state laws related to the acceptance andtransfer of a prescription drug, including 21 U.S.C. Chapter 9, Subchapter V, Part H,Pharmaceutical Distribution Supply Chain;(c)  shall, before accepting or dispensing a prescription drug under the program, inspecteach prescription drug to determine whether the prescription drug is an eligible prescriptiondrug;(d)  may dispense an eligible prescription drug to a medically indigent individual who:(i)  is a resident of the state; and(ii)  has a prescription issued by a practitioner;(e)  may charge a handling fee, adopted by the division under Section 63J-1-504; and(f)  may not accept, transfer, or dispense a prescription drug in violation of the federalFood, Drug, and Cosmetic Act, 21 U.S.C. Sec. 301 et seq.     58-17b-906.A person is not liable for injury, death, or loss of property based solely on the fact thatthe person donated, accepted, or dispensed an eligible prescription drug under this part.     58-17b-907.The rules made by the division under Subsection 58-17b-903(2)(b) shall include:(1)  registration requirements to establish the eligibility of a pharmacy to participate inthe program;(2)  a formulary that includes all eligible prescription drugs approved by the federalFood and Drug Administration;(3)  standards and procedures for:(a)  verifying whether a pharmacy or pharmacist participating in the program is licensedand in good standing with the board;(b)  handling of a donated eligible prescription drug, including:(i)  acceptance;(ii)  identification, including redundant criteria for verification;(iii)  documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history,and statements;(iv)  safe storage;(v)  security;(vi)  inspection;(vii)  transfer; and(viii)  dispensing;(c)  a pharmacist or licensed pharmacy technician working in or consulting with aparticipating eligible donor;(d)  disposition of a donated prescription drug that is a controlled substance;(e)  record keeping regarding:(i)  the eligible donor that donated each prescription drug;(ii)  the identification and evaluation of a donated prescription drug by a pharmacist orlicensed pharmacy technician; and(iii)  the dispensing or disposition of a prescription drug;(f)  determining the status of a medically indigent individual;(g)  labeling requirements to:(i)  ensure compliance with patient privacy laws relating to:(A)  an individual who receives an eligible prescription drug; and(B)  patient information that may appear on a donated prescription drug;(ii)  clearly identify an eligible prescription drug dispensed under the program; and(iii)  communicate necessary information regarding the manufacturer's recommendedexpiration date or the beyond use date; and(h)  ensuring compliance with the requirements of this part;(4)  a process for seeking input from:(a)  the Department of Health, created in Section 26-1-4, to establish program standardsand procedures for assisted living facilities and nursing care facilities; and(b)  the Division of Substance Abuse and Mental Health, created in Section62A-15-103, to establish program standards and procedures for mental health and substanceabuse clients; and(5)  the creation of a special training program that a pharmacist and a licensed pharmacytechnician at an eligible pharmacy must complete before participating in the program.Full text:



1     CHARITABLE PRESCRIPTION DRUG RECYCLING2     PROGRAM3     2016 GENERAL SESSION4     STATE OF UTAH5     Chief Sponsor:  Gage Froerer6     Senate Sponsor:  ____________7      8     LONG TITLE9     General Description:10          This bill creates a program that allows certain pharmacies to accept and dispense11     donated unused prescription medications to certain individuals.12     Highlighted Provisions:13          This bill:14                amends the Pharmacy Practice Act;15                defines terms;16                directs the Division of Occupational and Professional Licensing (DOPL) to make17     rules, in consultation with the Utah State Board of Pharmacy, to create a charitable18     prescription drug recycling program;19                establishes criteria for prescription drugs eligible for the program;20                establishes requirements for donors and pharmacies;21                limits the liability of program participants;22                directs DOPL to make rules establishing certain requirements, standards,23     procedures, and processes; and24                makes technical changes.25     Money Appropriated in this Bill:26          None27     Other Special Clauses:28          None29     Utah Code Sections Affected:30     AMENDS:31          58-17b-502, as last amended by Laws of Utah 2015, Chapter 33632          58-17b-503, as last amended by Laws of Utah 2011, Chapter 36633     ENACTS:34          58-17b-901, Utah Code Annotated 195335          58-17b-902, Utah Code Annotated 195336          58-17b-903, Utah Code Annotated 195337          58-17b-904, Utah Code Annotated 195338          58-17b-905, Utah Code Annotated 195339          58-17b-906, Utah Code Annotated 195340          58-17b-907, Utah Code Annotated 195341      42     Be it enacted by the Legislature of the state of Utah:43          Section 1.  Section 58-17b-502 is amended to read:44          58-17b-502. Unprofessional conduct.45          "Unprofessional conduct" includes:46          (1)  willfully deceiving or attempting to deceive the division, the board, or their agents47     as to any relevant matter regarding compliance under this chapter;48          (2) (a)  except as provided in Subsection (2)(b):49          (i)  paying or offering rebates to practitioners or any other health care providers, or50     receiving or soliciting rebates from practitioners or any other health care provider; or51          (ii)  paying, offering, receiving, or soliciting compensation in the form of a commission,52     bonus, rebate, kickback, or split fee arrangement with practitioners or any other health care53     provider, for the purpose of obtaining referrals.54          (b)  Subsection (2)(a) does not apply to:55          (i)  giving or receiving price discounts based on purchase volume;56          (ii)  passing along pharmaceutical manufacturer's rebates; or57          (iii)  providing compensation for services to a veterinarian.58          (3)  misbranding or adulteration of any drug or device or the sale, distribution, or59     dispensing of any outdated, misbranded, or adulterated drug or device;60          (4)  engaging in the sale or purchase of drugs or devices that are samples or packages61     bearing the inscription "sample" or "not for resale" or similar words or phrases;62          (5)  except as provided in Section 58-17b-503 or Part 9, Charitable Prescription Drug63     Recycling Act, accepting back and redistributing [of] any unused drug, or a part of it, after it64     has left the premises of any pharmacy, unless the drug is in a unit pack, as defined in Section65     58-17b-503, or the manufacturer's sealed container, as defined in rule;66          (6)  an act in violation of this chapter committed by a person for any form of67     compensation if the act is incidental to the person's professional activities, including the68     activities of a pharmacist, pharmacy intern, or pharmacy technician;69          (7)  violating Federal Title II, P.L. 91, Controlled Substances Act, Title 58, Chapter 37,70     Utah Controlled Substances Act, or rules or regulations adopted under either act;71          (8)  requiring or permitting pharmacy interns or technicians to engage in activities72     outside the scope of practice for their respective license classifications, as defined in this73     chapter and division rules made in collaboration with the board, or beyond their scope of74     training and ability;75          (9)  administering:76          (a)  without appropriate training, as defined by rule;77          (b)  without a physician's order, when one is required by law; and78          (c)  in conflict with a practitioner's written guidelines or written protocol for79     administering;80          (10)  disclosing confidential patient information in violation of the provisions of the81     Health Insurance Portability and Accountability Act of 1996 or other applicable law;82          (11)  engaging in the practice of pharmacy without a licensed pharmacist designated as83     the pharmacist-in-charge;84          (12)  failing to report to the division any adverse action taken by another licensing85     jurisdiction, government agency, law enforcement agency, or court for conduct that in86     substance would be considered unprofessional conduct under this section; and87          (13)  as a pharmacist or pharmacy intern, compounding a prescription drug in a dosage88     form which is regularly and commonly available from a manufacturer in quantities and89     strengths prescribed by a practitioner.90          Section 2.  Section 58-17b-503 is amended to read:91          58-17b-503. Exception to unprofessional conduct.92          (1)  For purposes of this section:93          (a)  "Licensed intermediate care facility for people with an intellectual disability" means94     an intermediate care facility for people with an intellectual disability that is licensed as a95     nursing care facility or a small health care facility under Title 26, Chapter 21, Health Care96     Facility Licensing and Inspection Act.97          (b)  "Nursing care facility" [has the same definition as] means the same as that term is98     defined in Section 26-21-2.99          (c)  "Unit pack" means a tamper-resistant nonreusable single-dose single-drug package100     with identification that indicates the lot number and expiration date for the drug.101          (2)  [Notwithstanding the provisions of Subsection 58-17b-502(5), a] A pharmacist102     may:103          (a)  accept and redistribute an unused drug under Part 9, Charitable Prescription Drug104     Recycling Act; or105          (b)  accept back and redistribute any unused drug, or a part of it, after it has left the106     premises of the pharmacy if:107          [(a)] (i)  the drug was prescribed to a patient in a nursing care facility, [a] licensed108     intermediate care facility for people with an intellectual disability, or state prison facility,109     county jail, or state hospital;110          [(b)] (ii)  the drug was stored under the supervision of a licensed health care provider111     according to manufacturer recommendations;112          [(c)] (iii)  the drug is in a unit pack or in the manufacturer's sealed container;113          [(d)] (iv)  the drug was returned to the original dispensing pharmacy;114          [(e)] (v)  the drug was initially dispensed by a licensed pharmacist or licensed pharmacy115     intern; and116          [(f)] (vi)  accepting back and [redistribution] redistributing of the drug complies with117     federal Food and Drug Administration and Drug Enforcement Administration regulations.118          Section 3.  Section 58-17b-901 is enacted to read:119     Part 9.  Charitable Prescription Drug Recycling Act120          58-17b-901. Title.121          This part is known as the "Charitable Prescription Drug Recycling Act."122          Section 4.  Section 58-17b-902 is enacted to read:123          58-17b-902. Definitions.124          As used in this part:125          (1)  "Assisted living facility" means the same as that term is defined in Section 26-21-2.126          (2)  "Cancer drug" means a drug that controls or kills neoplastic cells and includes a127     drug used in chemotherapy to destroy cancer cells.128          (3)  "Charitable clinic" means a charitable nonprofit corporation that:129          (a)  holds a valid exemption from federal income taxation issued under Section 501(a),130     Internal Revenue Code;131          (b)  is exempt from federal income taxation under Section 501(c)(3), Internal Revenue132     Code;133          (c)  provides, on an outpatient basis, for a period of less than 24 consecutive hours, to134     an individual not residing or confined at a facility owned or operated by the charitable135     nonprofit corporation:136          (i)  advice;137          (ii)  counseling;138          (iii)  diagnosis;139          (iv)  treatment;140          (v)  surgery; or141          (vi)  care or services relating to the preservation or maintenance of health; and142          (d)  has a licensed outpatient pharmacy.143          (4)  "Charitable pharmacy" means an eligible pharmacy that is operated by a charitable144     clinic.145          (5)  "County health department" means the same as that term is defined in Section146     26A-1-102.147          (6)  "Donated prescription drug" means a prescription drug that an eligible donor148     donates to an eligible pharmacy under the program.149          (7)  "Eligible donor" means a donor that donates a prescription drug from within the150     state and is:151          (a)  a nursing care facility;152          (b)  an assisted living facility;153          (c)  a licensed intermediate care facility for people with an intellectual disability;154          (d)  a manufacturer;155          (e)  a pharmaceutical wholesale distributor;156          (f)  an eligible pharmacy; or157          (g)  a physician's office.158          (8)  "Eligible pharmacy" means a pharmacy that:159          (a)  is registered by the division as eligible to participate in the program; and160          (b)  is operated by:161          (i)  a county;162          (ii)  a county health department;163          (iii)  a pharmacy under contract with a county health department;164          (iv)  the Department of Health, created in Section 26-1-4;165          (v)  the Division of Substance Abuse and Mental Health, created in Section166     62A-15-103; or167          (vi)  a charitable clinic.168          (9)  "Eligible prescription drug" means a prescription drug, described in Section169     58-17b-904, that is not a controlled substance.170          (10)  "Licensed intermediate care facility for people with an intellectual disability"171     means the same as that term is defined in Section 58-17b-503.172          (11)  "Medically indigent individual" means an individual who:173          (a)  is eligible to receive Medicaid or Medicare; or174          (b)  does not have health insurance and lacks reasonable means to purchase prescribed175     medications.176          (12)  "Nursing care facility" means the same as that term is defined in Section177     26-18-501.178          (13)  "Physician's office" means a fixed medical facility that:179          (a)  is staffed by a physician, physician's assistant, nurse practitioner, or registered180     nurse, licensed under Title 58, Occupations and Professions; and181          (b)  treats an individual who presents at, or is transported to, the facility.182          (14)  "Program" means the Charitable Prescription Drug Recycling Program created in183     Section 58-17b-903.184          (15)  "Unit pack" means the same as that term is defined in Section 58-17b-503.185          (16)  "Unlawful conduct" means the same as that term is defined in Sections 58-1-501186     and 58-17b-501.187          (17)  "Unprofessional conduct" means the same as that term is defined in Sections188     58-1-501 and 58-17b-502.189          Section 5.  Section 58-17b-903 is enacted to read:190          58-17b-903. Charitable Prescription Drug Recycling Program -- Creation --191     Requirements.192          (1)  There is created the Charitable Prescription Drug Recycling Program.193          (2)  The division, in consultation with the board, shall:194          (a)  implement the program, on a statewide basis, to permit an eligible donor to transfer195     an eligible prescription drug to an eligible pharmacy for dispensing to a medically indigent196     individual;197          (b)  in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act,198     make rules necessary to implement the program; and199          (c)  provide technical assistance to entities that desire to participate in the program.200          Section 6.  Section 58-17b-904 is enacted to read:201          58-17b-904. Criteria for eligible prescription drugs.202          An eligible pharmacy may not accept or dispense an unused prescription drug under the203     program unless the unused prescription drug:204          (1) (a)  is in the original sealed unit pack; or205          (b)  is an injectable medication;206          (2) (a)  is unopened; or207          (b)  is a cancer drug packaged in an unopened single-unit dose that has been removed208     from a multi-dose package;209          (3)  is accepted and dispensed by the eligible pharmacy before:210          (a)  a beyond use date that appears on the label;211          (b)  the expiration date recommended by the manufacturer; or212          (c)  a date, established by division rule for a specific prescription drug, in accordance213     with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, that is later than the date in214     Subsection (3)(a) or (3)(b);215          (4) (a)  is not adulterated or mislabeled; and216          (b)  the pharmacist or licensed pharmacist technician accepting or dispensing the217     prescription drug does not have reason to believe that the prescription drug is adulterated or218     mislabeled.219          Section 7.  Section 58-17b-905 is enacted to read:220          58-17b-905. Participation in program -- Requirements -- Fees.221          (1)  An eligible donor or an eligible pharmacy may participate in the program.222          (2)  An eligible pharmacy:223          (a)  shall comply with all applicable federal and state laws related to the storage and224     distribution of a prescription drug;225          (b)  shall comply with all applicable federal and state laws related to the acceptance and226     transfer of a prescription drug, including 21 U.S.C. Chapter 9, Subchapter V, Part H,227     Pharmaceutical Distribution Supply Chain;228          (c)  shall, before accepting or dispensing a prescription drug under the program, inspect229     each prescription drug to determine whether the prescription drug is an eligible prescription230     drug;231          (d)  may dispense an eligible prescription drug to a medically indigent individual who:232          (i)  is a resident of the state; and233          (ii)  has a prescription issued by a practitioner;234          (e)  may charge a handling fee, adopted by the division under Section 63J-1-504; and235          (f)  may not accept, transfer, or dispense a prescription drug in violation of the federal236     Food, Drug, and Cosmetic Act, 21 U.S.C. Sec. 301 et seq.237          Section 8.  Section 58-17b-906 is enacted to read:238          58-17b-906. Liability of participating organizations and manufacturers.239          A person is not liable for injury, death, or loss of property based solely on the fact that240     the person donated, accepted, or dispensed an eligible prescription drug under this part.241          Section 9.  Section 58-17b-907 is enacted to read:242          58-17b-907. Rules made by the division.243          The rules made by the division under Subsection 58-17b-903(2)(b) shall include:244          (1)  registration requirements to establish the eligibility of a pharmacy to participate in245     the program;246          (2)  a formulary that includes all eligible prescription drugs approved by the federal247     Food and Drug Administration;248          (3)  standards and procedures for:249          (a)  verifying whether a pharmacy or pharmacist participating in the program is licensed250     and in good standing with the board;251          (b)  handling of a donated eligible prescription drug, including:252          (i)  acceptance;253          (ii)  identification, including redundant criteria for verification;254          (iii)  documentation, under 21 U.S.C. Sec. 360eee-1, of transaction information, history,255     and statements;256          (iv)  safe storage;257          (v)  security;258          (vi)  inspection;259          (vii)  transfer; and260          (viii)  dispensing;261          (c)  a pharmacist or licensed pharmacy technician working in or consulting with a262     participating eligible donor;263          (d)  disposition of a donated prescription drug that is a controlled substance;264          (e)  record keeping regarding:265          (i)  the eligible donor that donated each prescription drug;266          (ii)  the identification and evaluation of a donated prescription drug by a pharmacist or267     licensed pharmacy technician; and268          (iii)  the dispensing or disposition of a prescription drug;269          (f)  determining the status of a medically indigent individual;270          (g)  labeling requirements to:271          (i)  ensure compliance with patient privacy laws relating to:272          (A)  an individual who receives an eligible prescription drug; and273          (B)  patient information that may appear on a donated prescription drug;274          (ii)  clearly identify an eligible prescription drug dispensed under the program; and275          (iii)  communicate necessary information regarding the manufacturer's recommended276     expiration date or the beyond use date; and277          (h)  ensuring compliance with the requirements of this part;278          (4)  a process for seeking input from:279          (a)  the Department of Health, created in Section 26-1-4, to establish program standards280     and procedures for assisted living facilities and nursing care facilities; and281          (b)  the Division of Substance Abuse and Mental Health, created in Section282     62A-15-103, to establish program standards and procedures for mental health and substance283     abuse clients; and284          (5)  the creation of a special training program that a pharmacist and a licensed pharmacy285     technician at an eligible pharmacy must complete before participating in the program.Legislative Review NoteOffice of Legislative Research and General Counsel

